OpenEvidence says it’s pursuing ‘medical super-intelligence’
OpenEvidence says it’s pursuing ‘medical super-intelligence’
https://www.statnews.com/2026/01/12/openevidence-medical-super-intelligence-jpm-conference/
Publish Date: 2026-01-12 16:56:00
Source Domain: www.statnews.com
- Katie Palmer discusses telehealth, clinical artificial intelligence, and the health data economy, focusing on the impacts of digital health care on patients, providers, and businesses.
- OpenEvidence, a four-year-old startup, has gained significant attention with its chatbot for physicians, which answers clinical questions.
- The company raised $200 million twice last year, valuing it at over $6 billion, and an additional round is expected to potentially double its valuation to $12 billion.
- OpenEvidence’s presence at the J.P. Morgan Healthcare Conference reflects the growing investor interest in AI-driven health care solutions.
- The surge in funding for AI-based startups, including OpenEvidence, Abridge, and Hippocratic AI, indicates significant tech investment in health care applications ranging from drug discovery to patient care.
